SHIVOM – Revolution Health Future Platform that Uses Technology of Genome and Blockchain

The genome is the complete set of DNA of an organism, including all gen. Each genome contains all the information needed to build and maintain an organism. In humans, a copy of the entire genome, totaling more than 3 billion base pairs of DNA, present in all cells that have a nucleus. In the field of medicine, genome technology allowing family planning (restrictions and spacing of births, as well as infertility treatment) and nanotechnology allows cured diseases that often ended in death.

When great expectations arose from a finding, there arose a demand in the community. Because cancer is a matter of life and death, of course, this technology enthusiast worldwide. In the year 2013, the market of the genome is estimated at $11 billion and continues to widen. Based on that data, then the chance of the use of Genomic technologies will continue to grow. Shivom present as future health platform that uses the technology of Genome and Blockchain. What is Shivom? Why choose Shivom?

Introducing Shivom

Shivom is a system that works in the field of health. Rather SHIVOM is Genomic Health and platform-based blockchain which will allow the transition to value-based healthcare. Shivom focuses fixed on OMICS technology transformation with the convergence blockchain, artificial intelligence, and machine learning to enable a secure and personalized medicine with global scalability.

Shivom platform using blockchain technology to create an ecosystem of genomics. To make direct business-to-consumer is more open, fair and beneficial to all users, and it also ensures that any data that is owned by the donor data itself.

A project that is unique and empowering, Shivom will allow donors DNA data to collaborate with the makers of the revolutionary changes in biotechnology, healthcare industry, and government research institutions are ordained and give a contribution to an era of unprecedented medical miracles before.

Genomics for all people is the basis of the project and as tangible evidence Shivom founder Sally Eaves, Dr. Axel Schumacher and Gourish Singla visits rural communities in India to talk with local residents about their health care and one of its objectives is to improve global health challenges and opportunities which the genome technology can make a difference.

Genomic Medicine technology is very promising because it has the following advantages: Genome technologies make it possible to determine the most effective treatment for patients of this technology helps to carry out timely diagnostic, the prognosis of the disease. Based on the available information specialist can implement disease prevention healthy people Specialists can also set new targets, treat them with medication is most effective.

Project founder SHIVOM guarantee understanding the complexity of the variations in the human genome, so they believe that can ensure health Shivom genetic universal right, because they expect to collect no Data only on genetic variation a common, but also people from the greater difficulties they are scarce or difficult to access, such as those in the population by ethnic origin or geographically they are still little studied in the public Granaries data genome.

According to the developers of the platform technology-revolutionary, Shivom genomics and Blockchain will significantly improve the current situation. The genome of this drug can clarify understanding, enhance the effectiveness of the treatment around 7000 rare diseases and common (Oncology, cardiovascular disease, infection, neurodegenerative).

For the first time, precision treatment of ecosystems will be offering web market open to other providers to add not only genomic information but also the analysis and related applications and services to encourage personalized medicines. Shivom intends to broaden its services to form a global network of laboratories and research centers, as well as related genetic counselors and other related services.

Shivom service offers innovative solutions for patients with donor genome data. In the system, each participant can set its own genome and safely store them in the database. The ecosystem functions of ensuring full market open web to other users (supplier of drugs), representatives from research organizations, as well as insurance companies, patient support groups. The global Shivom platform operates on the principles of integrity, openness, and security.

Shivom Vision

• Accelerating the age of genomics

Every 7.6 billion people on Earth has a unique code stored in their genes that unlock the secrets of the appearance, the offspring, intellectual ability, health, and fitness. But, the ability to reveal this code predisposing to disease has been ignored.

• Improve global health

Now is the right time for the development community together for the challenge’s “genome ” in the next decade. Currently, several key players held the monopoly on genomic data and generate huge profits from selling it to a third party, usually without sharing revenue with the donor data.

• JumpStart medicine-based genomic precision

Shivom changed the dynamics of the healthcare market globally. Utilizing the most advanced technology Shivom including blockchain, cloud computing, sequencing the genome, artificial intelligence, and analytic data is great to bring medical genome into a new era.

• Make sure the level of the next data privacy

Shivom are at the forefront of data security. Shivom cryptographic uses state-of-the-art to add an extra level of security to the platform technology that goes beyond shivom blockchain for decentralization, protect any user data from cyber criminals

The advantages of the platform SHIVOM Shivom System has many positive features. Blockchain technology ensures the security of information. The data property of the donors themselves. This ensures a secure, transparent bridge for the company or organization that is interested in using the data to carry out the work planned. Advantages of the system are as follows: SHIVOM Donors have full rights, access to User material appreciated for distributing their own genome data pharmaceutical companies use the service to get information about Shivom health community to develop an effective drug dynamic Ecosystem shivom produced and repaired can eliminate potential obstacles to improving health

In this case, it is expected that Shivom in conjunction with companies such as genetic technology Limited and others, can improve the current treatment given to genetic data collected around the world, so that it becomes possible to convert that data into useful information and easily managed in extensive field research, such as the development of pharmaceuticals or the study of cancer.

Under this rationale, the shadow of genetic technologies Limited is acting on the NASDAQ Are genes; They represent without doubt the power of the technology that serves as an important support, because they have been staked by the project and form of decentralization SHIVOM sampling. It should be remembered that genetic technology was briefly Limited is a pioneer in the clinical diagnosis of breast cancer origin of sporadic, through the application of a test called BREVAGenplus.

Another important point is that this Association is promising treatments that truly ethical, because one goal of SHIVOM is respects the privacy of genetic data, so they rely on the technology Blockchain and storage in the cloud. However, this action is not the only concern for Shivom, because thanks to this last Association expected reinforcement in medical ethics in the field of genetics, something that is important to the Government of the United States, which constantly check the regulations in This field. In turn, the security offered by the project beyond what the chain block offers, as implementing advanced security formula.

In addition, thanks to developments in genetic engineering who applied for data collection, the new society Shivom hoping to gather DNA with a more appropriate interpretation, exceeding earlier expectations (which is already pretty high), with what will be possible in the short time to share genetic data on private areas really understandable because a new analysis of the genetic predecessor now available for Shivom, without Dunda, through the study of a perfect and secure.

In the first partnership of its kind, which will produce the first event in the world to market sale and token cryptocurrency, DeHedge has trim token Shivom’s OmiX (OMX) with a total of $3 million. Risk hedging platform, which helps protect contributors against all sorts of unexpected changes, can guarantee 50% coverage of risk hedging when events occur.

DeHedge aims to reduce the risk to zero token sales contribution. a strict selection process to project involves a panel of three experts who chose internal potential projects based on ‘ Respect ‘ Startup Manifesto. This is then presented to the founder of DeHedge, which accepts or rejects it. The first project is Shivom made it through the selection process.

DEHEDGE GROUP Ltd. is registered in the United Kingdom, is a group of companies that provides international solutions fintech hedging for contributors into currencies and tokens, as well as other financial services to cryptocurrency and market the token. DeHedge as risk hedging platform decentralized guarantee that contributors will be token sales compensated in case of fluctuations in exchange rates, fraud, and the cancellation of the project.

OMIX TOKEN

OmiX Token, this is a sign that the strength of Shivom ecosystem, as well as part of the governance system. The token is a primary key component that enables the service to buy, trade, another in the trading platform.

OmiX Token has many benefits, such as;

• Ability to obtain a premium service in ecosystem Shivom
• Ability to obtain a genome sequencing kit
• Ability to sponsor projects Sequencing
• Ability to gain access to health/fitness applications from 3rd party providers
• Ability to access the database of genomes
• Ability to pay donors for data/participation in research
• Ability for service providers to use the platform

ICO

Pre-sale starts on 16 April to 16 may 2018 with 10% bonus go down every day. ICO is going very well and very brief set your clock and be here at the right time.

Details Of The ICO

• Price: 1 ETH = 7000 OMX
• Platform: Ethereum
• Soft cap: 15,000 ETH
• Hard cap: 75,000 ETH
• Tokens for sale: 990 million

For more information, please visit:

WEBSITE: https://shivom.io/
ANN THREAD: https://bitcointalk.org/index.php?topic=3204563.0
WHITEPAPER: https://shivom.io/files/Shivom-Executive-Summary.pdf
FACEBOOK: https://www.facebook.com/ProjectShivom
TWITTER: https://twitter.com/projectshivom
TELEGRAM: https://t.me/projshivom
REDDIT: https://www.reddit.com/r/Shivom/
MEDIUM: https://medium.com/@projectshivom
YOUTUBE: https://www.youtube.com/c/ProjectShivom
INSTAGRAM: https://www.instagram.com/projectshivom
LINKEDIN: https://www.linkedin.com/company/project-shivom

Username: Kenzi182
Bitcointalk Profile: https://bitcointalk.org/index.php?action=profile;u=1209283
Ethereum Address: 0x38086aD53B04250Ca71457eC5579258e3835048c